Short description
Quanterix is a biotechnology company that develops ultrasensitive biomarker detection for healthcare.
Description
Quanterix Corporation is developing a novel platform for single-molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs.
The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’s technology is designed to enable much earlier disease detection, better prognosis, and precise treatment methods to improve the quality of life and longevity of the population for generations to come.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Billerica, Massachusetts, United States, North America
Founded on
January 1, 2007
Exited on
December 6, 2017
Went public on
December 6, 2017
Stock symbol
QTRX
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noway Youcantaccess, Blurry Noaccess, Noaccess, Blurry Noaccess, Nopepepe, Blurry Noaccess, Nopepepe, Blurry Noaccess, Noway Youcantaccess, Nopepepe, Cannot Access, Blurry Noaccess
Sign in for full access
Founders
David R. Walt